NEW YORK (GenomeWeb) – Agilent Technologies announced today that it will partner with Bay Area lab automation firm Transcriptic to add several Agilent Genomics product lines for mutagenesis and cloning to the protocol library within the Transcriptic robotic cloud laboratory, including QuikChange site-directed mutagenesis kits.
The Transcriptic platform allows for remote, web-based control of life science research, enabling researchers to scale up experiments and reduce human error. The firm is building robotically-driven "workcells" — self-contained boxes filled with automated molecular biology laboratory equipment. Transcriptic has previously partnered with CRISPR design software firm Desktop Genetics to make guide RNA libraries for large-scale screening experiments.
In a statement, Transcriptic COO Yvonne Linney said that Agilent's QuikChange kits carried a reputation for reliability and ease-of-use, and that the deal will allow researchers to use many mutants to produce large data sets for exploring protein function.
Financial and other terms of the collaboration were not disclosed.